Ranking Big Pharma’s performance on access to medicines
Diabetes and cancer are becoming bigger problems in the developing world, but companies aren’t making treatments easily available.
Important work by
highlights need to ensure #access2meds to tackle the rise of #NCD in LICs. This is currently addressed in 54% of communicable diseases projects vs only 5% of cancer projects.